Form 483

The Mount Sinai Hospital Form 483, 2024-07-02

FDA issued a Form 483 to The Mount Sinai Hospital on 2024-07-02 with 3 public-safe observations.

483· Form 483 issuedBiologics3 observations

The Mount Sinai Hospital · New York, United States · Issued July 2, 2024

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

2 Jul 2024
21 CFR 606.100(b)

Establish, maintain and follow manufacturing SOPs

Cited by Irina Gaberman

2 Jul 2024
21 CFR 606.160(a)(1)

Concurrent documentation

Cited by Irina Gaberman

2 Jul 2024
21 CFR 606.160(b)

Required records

Cited by Irina Gaberman

Inspected site

TMThe Mount Sinai HospitalNew York, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 606.100(b)Cited across public-safe Form 483 observations1x
21 CFR 606.160(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 606.160(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 3 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere